BioCentury
ARTICLE | Financial News

Kiniksa upsizes IPO, raises $152.6M

May 24, 2018 4:13 AM UTC

Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) gained $1.47 to $19.47 Thursday after raising $152.6 million through the sale of 8.5 million shares at $18 in an upsized IPO underwritten by Goldman Sachs, J.P. Morgan, JMP Securities and Wedbush.

Kiniksa priced the offering at the midpoint of its proposed range. The price valued the company at $871.9 million...

BCIQ Company Profiles

Kiniksa Pharmaceuticals Ltd.